Search Results - "Hiltunen, Saara"

Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin? by Puolanne, Anna-Maija, Qadri, Sami, Vesterinen, Tiina, Hiltunen, Saara, Mustonen, Aaro, Kurki, Samu, Kolho, Kaija-Leena, Arola, Johanna, Färkkilä, Martti

“…Background: In the inflammatory bowel diseases, chronic inflammation predisposes to dysplasia and colorectal carcinoma, leading to the need of surveillance…”
Get full text

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study by Gauffin, Oskar, Brand, Judith S., Vidlin, Sara Hedfors, Sartori, Daniele, Asikainen, Suvi, Català, Martí, Chalabi, Etir, Dedman, Daniel, Danilovic, Ana, Duarte-Salles, Talita, García Morales, Maria Teresa, Hiltunen, Saara, Jödicke, Annika M., Lazarevic, Milan, Mayer, Miguel A., Miladinovic, Jelena, Mitchell, Joseph, Pistillo, Andrea, Ramírez-Anguita, Juan Manuel, Reyes, Carlen, Rudolph, Annette, Sandberg, Lovisa, Savage, Ruth, Schuemie, Martijn, Spasic, Dimitrije, Trinh, Nhung T. H., Veljkovic, Nevena, Vujovic, Ankica, de Wilde, Marcel, Zekarias, Alem, Rijnbeek, Peter, Ryan, Patrick, Prieto-Alhambra, Daniel, Norén, G. Niklas

“…Introduction Individual case reports are the main asset in pharmacovigilance signal management. Signal validation is the first stage after signal detection and…”
Get full text